SCHEMBL3620127

SCHEMBL3620127

O=C(O)Cc1csc(NS(=O)(=O)c2ccc(-c3ccon3)s2)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PFKFB3 Q16875 1/20 0.53
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
ALDH1A1 P00352 3/20 0.43
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
CDK5 Q00535 1/20 0.40
CDK5R1 Q15078 1/20 0.40
MMP8 P22894 4/20 0.39
MMP3 P08254 2/20 0.39
POLB P06746 2/20 0.39
MAPT P10636 4/20 0.39
GAA P10253 3/20 0.39
NPC1 O15118 1/20 0.39
NFKB1 P19838 1/20 0.39
RAB9A P51151 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
PKM P14618 1/20 0.38
CTPS1 P17812 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3254954 0.82 PFKFB3 (0.55) PFKFB3KMT2AMEN1ALDH1A1MMP8
SCHEMBL3623789 0.80 PFKFB3 (0.58) PFKFB3KMT2AMEN1ALDH1A1CYP2C9
SCHEMBL3619962 0.79 KMT2A (0.48) KMT2AMEN1ALDH1A1CYP2C9CYP2C19
SCHEMBL3617632 0.77 GAA (0.58) KMT2AMEN1ALDH1A1CYP2C9CYP2C19
SCHEMBL3613210 0.76 ALDH1A1 (0.55) KMT2AMEN1ALDH1A1CYP2C9CYP2C19
SCHEMBL3620239 0.73 GAA (0.47) KMT2AMEN1ALDH1A1CYP2C9CYP2C19
SCHEMBL3622069 0.73 CCKBR (0.46) KMT2AMEN1ALDH1A1CYP2C9CYP2C19
SCHEMBL3619367 0.72 ALDH1A1 (0.72) KMT2AMEN1ALDH1A1CYP2C9CYP2C19
SCHEMBL7538030 0.72 PFKFB3 (0.59) PFKFB3KMT2AMEN1ALDH1A1MMP8
SCHEMBL3621458 0.72 ALDH1A1 (0.58) KMT2AMEN1ALDH1A1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100113435-A1 INHIBITORS OF 11-BETA-HYDROXY STERIOD DEHYDROGENASE TYPE 1 BIOVITRUM AB 2010-05-06 US claimed
US-7618961-B2 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB (SE) 2009-11-17 US claimed
US-20040224996-A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB (SE) 2004-11-11 US claimed
US-20100113435-A1 INHIBITORS OF 11-BETA-HYDROXY STERIOD DEHYDROGENASE TYPE 1 BIOVITRUM AB 2010-05-06 US disclosed
US-7618961-B2 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB (SE) 2009-11-17 US disclosed
US-20040224996-A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB (SE) 2004-11-11 US disclosed
EP-1283831-A1 INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1 BIOVITRUM AB (SE) 2003-02-19 EP disclosed
WO-2001090090-A1 INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1 BIOVITRUM AB (SE) 2001-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040224996-A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 HSD11B1, HSD17B1, HSD11B2 PFKFB3 2569/4885KMT2A 3300/4885MEN1 832/4885
US-20100113435-A1 INHIBITORS OF 11-BETA-HYDROXY STERIOD DEHYDROGENASE TYPE 1 HSD11B1, HSD17B1, HSD3B1 PFKFB3 1963/4885KMT2A 3769/4885MEN1 752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.